The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment.

The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment.

Item
http://www.wikidata.org/entity/Q33565959
Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus.Best practice in primary care pathology: review 22012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.Glucocorticoid usage in giant cell arteritis over six decades (1950 to 2009).Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patientsGlucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy.Medical management of polymyalgia rheumatica.Polymyalgia rheumatica: 125 years of progress?Polymyalgia rheumatica: 125 years of epidemiological progress?Polymyalgia rheumatica: strategies for efficient practice and quality assurance.Clinical characteristics and prognostic factors for relapse in patients with polymyalgia rheumatica (PMR).Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis. A prospective two-year study in 273 patients.Assessment of 2012 EULAR/ACR new classification criteria for polymyalgia rheumatica in Japanese patients diagnosed using Bird's criteria.2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
P2860

The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment.

Item
http://www.wikidata.org/entity/Q33565959
description
1993 nî lūn-bûn
@nan
1993 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
The clinical and laboratory co ...... first two months of treatment.
@ast
The clinical and laboratory co ...... first two months of treatment.
@en
The clinical and laboratory co ...... first two months of treatment.
@nl
type
label
The clinical and laboratory co ...... first two months of treatment.
@ast
The clinical and laboratory co ...... first two months of treatment.
@en
The clinical and laboratory co ...... first two months of treatment.
@nl
prefLabel
The clinical and laboratory co ...... first two months of treatment.
@ast
The clinical and laboratory co ...... first two months of treatment.
@en
The clinical and laboratory co ...... first two months of treatment.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
The clinical and laboratory co ...... first two months of treatment.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932